# Next-generation viral detection through AI-enhanced nanotechnology: advances, challenges, and future directions

**Authors:** Pankaj Garg, Gargi Singhal, Sharad S. Singhal

PMC · DOI: 10.3389/fmolb.2026.1750124 · Frontiers in Molecular Biosciences · 2026-03-18

## TL;DR

This paper reviews how combining AI and nanotechnology can improve virus detection, prediction, and response, while addressing challenges and future needs.

## Contribution

The paper provides an interdisciplinary overview of AI-nanotechnology integration in virology, identifying challenges and proposing future directions for global virus surveillance.

## Key findings

- AI and nanotechnology together enable rapid and sensitive viral detection systems.
- Nanosensors and AI algorithms can predict viral mutations and outbreak trajectories.
- Integration supports adaptive public health responses but requires clinical validation.

## Abstract

Emerging viral outbreaks, such as the COVID-19 pandemic, have highlighted the critical need for rapid, accurate, and scalable virus detection systems. This review aims to explore the integration of artificial intelligence (AI) and nanotechnology as a transformative approach for real-time virus prediction, monitoring, and management. The review systematically analyzes how machine learning (ML) and deep learning (DL) algorithms are being applied to identify viral mutations, forecast outbreak trajectories, and analyze complex virological data. It also highlights recent advances in nanotechnology, including the development of nanosensors, nanoparticle-based diagnostics, and lab-on-chip devices. The synergy between AI and nanotechnology is examined through selected case studies and near-real-world implementation efforts. The convergence of AI and nanotechnology represents a promising translational pipeline toward highly sensitive, rapid, and personalized viral detection systems, with substantial clinical validation and regulatory maturation still required before routine deployment. When combined, AI enhances the interpretability and responsiveness of nanotech-based diagnostics, while nanodevices provide high-resolution data for AI-driven prediction models. This integration supports more adaptive, data-driven public health responses. This review presents an up-to-date, interdisciplinary overview of AI–nanotech integration in virology. It identifies current challenges such as data privacy, algorithmic bias, and regulatory barriers, while proposing future directions for personalized and globally inclusive virus surveillance systems. The combined power of biological insight and technological innovation outlines an emerging paradigm for managing viral threats, contingent upon continued translational validation and real-world implementation.

Infographic divided into two sections: the left details an operational workflow for integrated AI-nanotechnology in viral diagnosis and prediction, including steps from sample input, data preprocessing, AI inference, AI outputs, to deployment and feedback. The right highlights future directions and bottlenecks, listing AI functional roles, nanotechnology platforms, deployment and feedback, translational bottlenecks, and clinical and public health impact, all centered around AI-nanotechnology convergence for viral diagnostics.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13038447/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13038447/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC13038447/full.md

---
Source: https://tomesphere.com/paper/PMC13038447